ABSTRACT The histidine decarboxylase (L-histidine carboxylyase, EC 4.1.1.22) activity of whole W/W mouse embryos, which are devoid of mast cells, remained very low and did not show the rapid increase before birth (17-20 days of gestation) seen in wildtype +/+ embryos. During the same period, the histamine content also remained very low and no mast cells were detected in the W/W embryos, in contrast to the large increase in both histamine content and number of mast cells in wild-type embryos. These findings imply that the histamine in embryos is largely derived
W/W embryos, in contrast to the large increase in both histamine content and number of mast cells in wild-type embryos. These findings imply that the histamine in embryos is largely derived from mast cells. In +/+ mice, histidine decarboxylase activity decreased rapidly soon after birth without concomitant decrease in histamine content or number of mast cells, suggesting that the enzyme activity in mast cells is regulated by some unknown mechanism.
Histamine plays various roles as one of the biogenic amines; it is probably liberated from both mast cells and nonmast cells. The histamine liberated from mast cells is involved in anaphylactic and allergic reactions, inflammation and so on, and that liberated from nonmast cells is involved in gastric acid secretion, neurotransmission, and rapid tissue proliferation, such as growth of rodent embryos, healing of wounds, and growth of certain experimental tumors (1) (2) (3) (4) (5) (6) . The idea that it is produced by nonmast cells was proposed by Kahlson and Rosengren (1, 2) and by Schayer (3) , but the nature of these nonmast cells secreting histamine is unknown.
The most dramatic and best-known example of nonmast cell histamine is seen during the development of rodent embryos. Namely, a marked increase in urinary excretion of histamine occurs in pregnant rodents, such as rats, mice, and hamsters, in the last few days ofpregnancy, with a return to low levels after delivery (1, 2) ; in parallel with these changes, the histidine decarboxylase (HisDCase; L-histidine carboxy-lyase, EC 4.1.1.22) activity of whole embryos shows a sharp increase after day 16 of gestation, reaches a plateau on day 18, and decreases rapidly after birth. Kahlson and Rosengren used the term "nascent histamine" (1, 2) to distinguish this histamine from histamine released from mast cells, and proposed that it is formed as a result of increase in histamine-forming capacity. Schayer noted a similar marked increase in HisDCase activity when certain tissues were exposed to irritants, endotoxins, or infectious agents (3) . He referred to this increased HisDCase as "inducible HisDCase," and suggested that it was derived from nonmast cells. Histamine produced by inducible HisDCase in nonmast cells is not stored in the cells but released immediately after its synthesis, thus having a rapid turnover (3, 4) . In contrast, histamine in mast cells has a slow turnover rate, is stored in granules, and is released upon stimulus (4, 5) . Although the views of Kahlson and Rosengren (1, 2) and Schayer (3) are very interesting, they seem to be based on rather indirect evidence: mast cells are so ubiquitous in tissues that, in studies using normal tissues, it is impossible to exclude the contribution of mast cells. Until now, no system has been available for demonstrating the presence of histamine in nonmast cells.
Kitamura et al. (7) 
MATERIALS AND METHODS
Mice. WB-(W/+, +/+) mice were raised in our laboratory using parental stocks originally obtained from The Jackson Laboratory. W/W embryos were obtained by mating female WB-W/+ mice with male WB-W/+ mice. The day on which vaginal plugs were found was taken as the first day of pregnancy. Mice were killed by cervical dislocation between day 13 and day 20 of pregnancy, and the embryos were removed. W/W embryos were distinguished from their W/+ and +/+ litter mates by the color of their skin, because they were anemic (11) . +/+ Embryos were obtained from WB-+/+ females mated with WB-+/+ males.
Analytical Procedures. Most embryos and newborn mice were stored at -800C for analyses, but a few were fixed in 10% formalin in phosphate buffer, pH 7.2, for determination of the number of mast cells. The procedure for determining the number of mast cells in subcutaneous tissue of embryos has been described (12) . Whole body extracts of embryos were prepared as described (10) Fig. 1 . The specific HisDCase activity of crude extracts of +/+ mouse embryos began to increase rapidly on day 16 reaching a peak on day 18 of gestation, when the enzyme activity was 105 times that on day 13 ofpregnancy. The activity decreased sharply after birth, being 1/17th of the peak value by day 3. In parallel with the increase in HisDCase, the specific histamine content and the number of mast cells began to increase on day 16 ofgestation but, unlike HisDCase activity, they did not decrease greatly after day 20, remaining higher than before day 16 of gestation. On the other hand, in W/W mouse embryos, neither the HisDCase activity nor the histamine content increased at all during the preparturition period. As predicted from genetic studies (7) , no mast cells were detected in subcutaneous tissues of mutant embryos.
DISCUSSION
We have examined the changes ofHisDCase activity, histamine content, and number of mast cells during development of +/+ and W/W mouse embryos. W/W mice are useful for determining whether histamine involved in fetal growth is derived from nonmast cells as nascent histamine (1, 2) because this mutant has no mast cells (7) . In +/+ mouse embryos, we confirmed the results of Kahlson and Rosengren that HisDCase activity increased significantly between day 17 and day 20 of gestation (1, 2) . Contrary to the idea that histamine formed by inducible HisDCase is not stored in cells but released and destroyed rapidly in situ, the histamine level of whole bodies of +/+ mice increased in parallel with the increase in HisDCase activity and the number of mast cells. Histamine has not previously been measured in whole embryos, but urinary histamine excretion in pregnant animals has been used as an indicator of histamine formation in vivo because nascent histamine has a fast turnover rate (1, 2) . In W/W mouse embryos, which have no mast cells (7), the HisDCase activity and the histamine content remained low and did not increase between day 17 and day 19 of gestation. Thus, the increased histamine content observed in +/+ mouse embryos during the preparturition period is derived from mast cells ofthe embryos, not from nonmast cells, as suggested by Kahlson and Rosengren (1, 2) . As W/W mice survived until sometime after birth even though they were smaller than +/+ mice during gestation and after birth, it seems unlikely that histamine is essential for maintenance and growth of embryos during gestation. The present study showed that rapid increase in HisDCase activity under certain conditions does not necessarily indicate that it occurs in nonmast cells. However, we have to test other conditions using the W/Wv mouse system, because there still remains the possibility that HisDCase deficiency and mast cell deficiency are independent in this mutant mouse.
It is interesting that, in +/+ mouse embryos, HisDCase activity reaches a peak on days 18 and 19 of gestation, begins to decrease on day 20, and becomes very low after birth, whereas the histamine content and the number of mast cells, which increase at the same times as the HisDCase activity, do not decrease later, but remain high even after birth. Two possible explanations for this dissociation ofHisDCase activity from the histamine and mast cell contents can be considered. (i) HisDCase, which is induced on day 16 (17) . Histamine synthesized in mast cells is stored in granules and released when necessary. Thus, unless mast cells are depleted of histamine, they will not need to synthesize more histamine. Radioimmunoassay of HisDCase using anti-HisDCase antibody should be useful for determining which of these possibilities is correct.
L-ornithine decarboxylase activity increases during development of embryos (19) . Recently, Fozard et aL (20) reported that inhibition of ornithine decarboxylase in mouse embryos in vivo by DL-a-difluoromethylornithine, an enzyme-activated irreversible inhibitor of the enzyme, resulted in arrest of embryonic development. Relative to the above discussion, it would be particularly interesting to test the effect ofL-a-fluoromethylhistidine, a suicide inhibitor of HisDCase (21), on growth of mouse and rat embryos, because increase in HisDCase in mouse and rat embryos during gestation is associated with its increase in the skin and liver, respectively (1, 2, 22) .
